Inactive Instrument

Highlights GENFIT Euronext Paris

Equities

GNFT

FR0004163111

End-of-day quote Euronext Paris Other stock markets
- ^PTS	-

22/05	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	MT
20/05	European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05	MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	20/05	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	14/05	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher	13/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	01/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26/04	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	17/04	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04	MT
Genfit: net loss widens in 2023	05/04	CF
Genfit S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	05/04	CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03/04	MT
Genfit: 41% sales growth in 2023	01/03	CF
GENFIT Announces Updates Following Acceptance of Elafibranor Filings in Primary Biliary Cholangitis	08/12	CI
Ipsen Confirms U.S. FDA Grants Priority Review for New Drug Application for Elafibranor for the Treatment of Rare, Cholestatic Liver Disease, PBC	07/12	CI
GENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+ as a Screening Tool for the Enrollment of Patients in Mash Clinical Trials	06/12	CI
Ipsen and GENFIT Announces Full Results from the Pivotal Phase III ELATIVE Trial	14/11	CI
GENFIT Announces Publication in Nature Medicine Confirming the Performance of Its Nash Diagnostic Technology	27/23/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GENFIT Euronext Paris

Equities

GNFT

FR0004163111

Highlights

Filters